T. Rowe Price Associates
ADAP

T. Rowe Price Associates’s Adaptimmune Therapeutics ADAP Stock Holding History

T. Rowe Price Associates’s Portfolio ADAP Stock Details ADAP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-73,922
Closed -$69K – 2885
2023
Q2 		$69K Buy
+73,922
New +$69K ﹤0.01% 2756